These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6401788)

  • 1. Evaluation of immunotherapeutic approaches for the potential treatment of infections caused by K1-positive Escherichia coli.
    Cross AS; Zollinger W; Mandrell R; Gemski P; Sadoff J
    J Infect Dis; 1983 Jan; 147(1):68-76. PubMed ID: 6401788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human monoclonal antibody with protective activity for Escherichia coli K1 and Neisseria meningitidis group B infections.
    Raff HV; Devereux D; Shuford W; Abbott-Brown D; Maloney G
    J Infect Dis; 1988 Jan; 157(1):118-26. PubMed ID: 3121759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo.
    Kim KS; Kang JH; Cross AS; Kaufman B; Zollinger W; Sadoff J
    J Infect Dis; 1988 Jan; 157(1):47-53. PubMed ID: 2447199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological properties of monoclonal antibodies specific for meningococcal polysaccharides: the protective capacity of IgM antibodies specific for polysaccharide group B.
    Moreno C; Hewitt J; Hastings K; Brown D
    J Gen Microbiol; 1983 Aug; 129(8):2451-6. PubMed ID: 6415230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to poly[(2----8)-alpha-N-acetylneuraminic acid] and poly[(2----9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1.
    Devi SJ; Robbins JB; Schneerson R
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7175-9. PubMed ID: 1908091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Escherichia coli K1 colominic acid-specific murine antibodies that are cross-protective against Neisseria meningitidis groups B, C, and Y.
    Park IH; Lin J; Choi JE; Shin JS
    Mol Immunol; 2014 Jun; 59(2):142-53. PubMed ID: 24603121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody 2-2-B kills K1-positive Escherichia coli in conjunction with cord blood neutrophils and sera, but not with spinal fluid.
    Cross AS; Wooldridge WH; Zollinger WD
    Pediatr Res; 1984 Aug; 18(8):770-2. PubMed ID: 6382138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci.
    Frosch M; Görgen I; Boulnois GJ; Timmis KN; Bitter-Suermann D
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1194-8. PubMed ID: 3919387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human monoclonal macroglobulin with specificity for alpha(2----8)-linked poly-N-acetyl neuraminic acid, the capsular polysaccharide of group B meningococci and Escherichia coli K1, which crossreacts with polynucleotides and with denatured DNA.
    Kabat EA; Nickerson KG; Liao J; Grossbard L; Osserman EF; Glickman E; Chess L; Robbins JB; Schneerson R; Yang YH
    J Exp Med; 1986 Aug; 164(2):642-54. PubMed ID: 3088209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine monoclonal antibodies for detection of antigens and culture identification of Neisseria meningitidis group B and Escherichia coli K-1.
    Krambovitis E; McIllmurray MB; Lock PA; Holzel H; Lifely MR; Moreno C
    J Clin Microbiol; 1987 Sep; 25(9):1641-4. PubMed ID: 3116036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1.
    Azmi FH; Lucas AH; Raff HV; Granoff DM
    Infect Immun; 1994 May; 62(5):1776-86. PubMed ID: 8168940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis.
    Pon RA; Lussier M; Yang QL; Jennings HJ
    J Exp Med; 1997 Jun; 185(11):1929-38. PubMed ID: 9166422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The form variation of the capsular polysaccharide K1 is not a critical virulence factor of Escherichia coli in a neonatal mouse model of infection.
    Colino J; Outschoorn I
    Microb Pathog; 1999 Oct; 27(4):187-96. PubMed ID: 10502459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine hybridoma antibodies enhance bactericidal activity of human cord blood against K1 Escherichia coli strains.
    Kim KS; Cross AS; Kaufmann B; Zollinger W; Sadoff J
    Pediatr Res; 1990 Dec; 28(6):667-70. PubMed ID: 1704500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal activity of two IgG2a murine monoclonal antibodies with distinct fine specificities for group B Neisseria meningitidis capsular polysaccharide.
    Hurpin CM; Carosella ED; Cazenave PA
    Hybridoma; 1992 Dec; 11(6):677-87. PubMed ID: 1284118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of immunization with Escherichia coli K1 antigen on the course of experimental infection of the urinary tract of the rat.
    Straube E; Nimmich W; Broschewitz U; Naumann G; Hacker K
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jul; 265(3-4):408-19. PubMed ID: 3314264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique intermolecular bactericidal epitope involving the homosialopolysaccharide capsule on the cell surface of group B Neisseria meningitidis and Escherichia coli K1.
    Jennings HJ; Gamian A; Michon F; Ashton FE
    J Immunol; 1989 May; 142(10):3585-91. PubMed ID: 2469720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide.
    Zollinger WD; Mandrell RE
    Infect Immun; 1983 Apr; 40(1):257-64. PubMed ID: 6403466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 20. Relative opsonic and protective activities of antibodies against K1, O and lipid A antigens of Escherichia coli.
    Welch WD; Martin WJ; Stevens P; Young LS
    Scand J Infect Dis; 1979; 11(4):291-301. PubMed ID: 93778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.